
Chinese General Practice ›› 2026, Vol. 29 ›› Issue (19): 2614-2620.DOI: 10.12114/j.issn.1007-9572.2024.0250
Special Issue: 内分泌代谢性疾病最新文章合辑; 社区卫生服务最新研究合辑
• General Practice/Community Health Service • Previous Articles Next Articles
Received:2025-10-15
Revised:2026-01-22
Published:2026-07-05
Online:2026-06-05
Contact:
ZHANG Xiaojuan
通讯作者:
张小娟
作者简介:作者贡献:
张小娟负责数据的整理、分析和论文撰写、修改完善,并对文章负责;刘阳、彭博、叶媛负责数据的收集;朱坤协助优化完善文章分析框架和思路。
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0250
| 区域 | 机构数 | 心电图机 | 末梢血糖仪 | ||||
|---|---|---|---|---|---|---|---|
| 1台 | 2台 | 3台及以上 | 1~3台 | 4~6台 | 7台及以上 | ||
| 东部 | 1 427 | 45(3.15) | 771(54.03) | 611(42.82) | 146(10.23) | 360(25.23) | 921(64.54) |
| 中部 | 1 503 | 68(4.52) | 992(66.00) | 443(29.47) | 278(18.50) | 589(39.19) | 636(42.32) |
| 西部 | 788 | 25(3.17) | 331(42.01) | 432(54.82) | 116(14.72) | 224(28.43) | 448(56.85) |
| χ2值 | 151.41 | 147.31 | |||||
| P值 | <0.001 | <0.001 | |||||
Table 1 Availability of electrocardiographs and peripheral blood glucose meters in primary medical and health institutions in eastern, central, and western regions
| 区域 | 机构数 | 心电图机 | 末梢血糖仪 | ||||
|---|---|---|---|---|---|---|---|
| 1台 | 2台 | 3台及以上 | 1~3台 | 4~6台 | 7台及以上 | ||
| 东部 | 1 427 | 45(3.15) | 771(54.03) | 611(42.82) | 146(10.23) | 360(25.23) | 921(64.54) |
| 中部 | 1 503 | 68(4.52) | 992(66.00) | 443(29.47) | 278(18.50) | 589(39.19) | 636(42.32) |
| 西部 | 788 | 25(3.17) | 331(42.01) | 432(54.82) | 116(14.72) | 224(28.43) | 448(56.85) |
| χ2值 | 151.41 | 147.31 | |||||
| P值 | <0.001 | <0.001 | |||||
| 区域 | 机构数 | 1~3种 | 4~6种 | 7~9种 | 10种及以上 |
|---|---|---|---|---|---|
| 东部 | 1 262 | 88(6.97) | 345(27.34) | 570(45.17) | 259(20.52) |
| 中部 | 1 413 | 116(8.21) | 533(37.72) | 617(43.67) | 147(10.40) |
| 西部 | 749 | 84(11.21) | 313(41.79) | 292(38.99) | 60(8.01) |
| χ2值 | 120.88 | ||||
| P值 | <0.001 | ||||
Table 2 Status of essential antihypertensive drugs
| 区域 | 机构数 | 1~3种 | 4~6种 | 7~9种 | 10种及以上 |
|---|---|---|---|---|---|
| 东部 | 1 262 | 88(6.97) | 345(27.34) | 570(45.17) | 259(20.52) |
| 中部 | 1 413 | 116(8.21) | 533(37.72) | 617(43.67) | 147(10.40) |
| 西部 | 749 | 84(11.21) | 313(41.79) | 292(38.99) | 60(8.01) |
| χ2值 | 120.88 | ||||
| P值 | <0.001 | ||||
| 区域 | 机构数 | 1~3种 | 4~6种 | 7~9种 | 10种及以上 |
|---|---|---|---|---|---|
| 东部 | 1 427 | 85(5.96) | 235(16.47) | 462(32.38) | 645(45.20) |
| 中部 | 1 503 | 134(8.92) | 474(31.54) | 585(38.92) | 310(20.63) |
| 西部 | 788 | 149(18.91) | 358(45.43) | 201(25.51) | 80(10.15) |
| χ2值 | 543.82 | ||||
| P值 | <0.001 | ||||
Table 3 Status of essential hypoglycemic drugs
| 区域 | 机构数 | 1~3种 | 4~6种 | 7~9种 | 10种及以上 |
|---|---|---|---|---|---|
| 东部 | 1 427 | 85(5.96) | 235(16.47) | 462(32.38) | 645(45.20) |
| 中部 | 1 503 | 134(8.92) | 474(31.54) | 585(38.92) | 310(20.63) |
| 西部 | 788 | 149(18.91) | 358(45.43) | 201(25.51) | 80(10.15) |
| χ2值 | 543.82 | ||||
| P值 | <0.001 | ||||
| 区域 | 每机构年诊疗高血压病人次 | 每机构年诊疗糖尿病人次 | 辖区每家应管理高血压患者机构年诊疗高血压病次数 | 辖区每家应管理糖尿病患者机构年诊疗糖尿病次数 |
|---|---|---|---|---|
| 东部 | 6 985(2 512,25 608) | 4 128(1 450,12 029) | 1.57(0.60,3.95) | 2.21(0.87,4.98) |
| 中部 | 3 348(1 475,7 200) | 1 794(745,3 654) | 0.98(0.41,2.22) | 1.40(0.58,3.26) |
| 西部 | 2 266(977,4 843) | 1 110(534,2 586) | 0.79(0.36,1.58) | 1.34(0.68,2.83) |
| 合计 | 3 848(1 563,9 653) | 2 160(859,5 676) | 1.06(0.44,2.62) | 1.67(0.70,3.78) |
| H值 | 396.30 | 401.49 | 152.36 | 83.39 |
| P值 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 4 Comparison of annual numbers of visits for hypertension and diabetes in primary medical and health institutions
| 区域 | 每机构年诊疗高血压病人次 | 每机构年诊疗糖尿病人次 | 辖区每家应管理高血压患者机构年诊疗高血压病次数 | 辖区每家应管理糖尿病患者机构年诊疗糖尿病次数 |
|---|---|---|---|---|
| 东部 | 6 985(2 512,25 608) | 4 128(1 450,12 029) | 1.57(0.60,3.95) | 2.21(0.87,4.98) |
| 中部 | 3 348(1 475,7 200) | 1 794(745,3 654) | 0.98(0.41,2.22) | 1.40(0.58,3.26) |
| 西部 | 2 266(977,4 843) | 1 110(534,2 586) | 0.79(0.36,1.58) | 1.34(0.68,2.83) |
| 合计 | 3 848(1 563,9 653) | 2 160(859,5 676) | 1.06(0.44,2.62) | 1.67(0.70,3.78) |
| H值 | 396.30 | 401.49 | 152.36 | 83.39 |
| P值 | <0.001 | <0.001 | <0.001 | <0.001 |
| 区域 | 高血压患者 | 糖尿病患者 | ||
|---|---|---|---|---|
| 签约率 | 续约率 | 签约率 | 续约率 | |
| 东部 | 88.64±16.88 | 80.76±21.10 | 88.42±17.06 | 80.04±21.44 |
| 中部 | 89.91±18.18 | 84.19±23.54 | 89.64±18.16 | 83.62±23.65 |
| 西部 | 88.89±17.21 | 79.09±24.77 | 89.16±16.67 | 78.63±24.86 |
| 合计 | 89.21±17.49 | 81.79±23.00 | 89.07±17.44 | 81.19±23.19 |
| F值 | 2.09 | 15.12 | 1.80 | 14.91 |
| P值 | 0.123 | <0.001 | 0.165 | <0.001 |
Table 5 Comparison of family doctor contract signing rate and renewal rate for patients with hypertension and diabetes in primary medical and health institutions in different regions
| 区域 | 高血压患者 | 糖尿病患者 | ||
|---|---|---|---|---|
| 签约率 | 续约率 | 签约率 | 续约率 | |
| 东部 | 88.64±16.88 | 80.76±21.10 | 88.42±17.06 | 80.04±21.44 |
| 中部 | 89.91±18.18 | 84.19±23.54 | 89.64±18.16 | 83.62±23.65 |
| 西部 | 88.89±17.21 | 79.09±24.77 | 89.16±16.67 | 78.63±24.86 |
| 合计 | 89.21±17.49 | 81.79±23.00 | 89.07±17.44 | 81.19±23.19 |
| F值 | 2.09 | 15.12 | 1.80 | 14.91 |
| P值 | 0.123 | <0.001 | 0.165 | <0.001 |
| 区域 | 高血压患者 | 糖尿病患者 | ||
|---|---|---|---|---|
| 规范管理率 | 血压控制率 | 规范管理率 | 血糖控制率 | |
| 东部 | 88.64±16.88 | 80.76±21.10 | 75.2±15.31 | 62.17±18.71 |
| 中部 | 89.91±18.18 | 84.19±23.54 | 81.93±14.77 | 75.27±17.06 |
| 西部 | 88.89±17.21 | 79.09±24.77 | 82.91±15.13 | 70.11±17.7 |
| 合计 | 89.21±17.49 | 81.79±23.00 | 79.70±15.44 | 69.15±18.77 |
| F值 | 48.60 | 76.03 | 83.67 | 198.47 |
| P值 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 6 Comparison of health management services for patients with hypertension and diabetes in primary medical and health institutions in different regions
| 区域 | 高血压患者 | 糖尿病患者 | ||
|---|---|---|---|---|
| 规范管理率 | 血压控制率 | 规范管理率 | 血糖控制率 | |
| 东部 | 88.64±16.88 | 80.76±21.10 | 75.2±15.31 | 62.17±18.71 |
| 中部 | 89.91±18.18 | 84.19±23.54 | 81.93±14.77 | 75.27±17.06 |
| 西部 | 88.89±17.21 | 79.09±24.77 | 82.91±15.13 | 70.11±17.7 |
| 合计 | 89.21±17.49 | 81.79±23.00 | 79.70±15.44 | 69.15±18.77 |
| F值 | 48.60 | 76.03 | 83.67 | 198.47 |
| P值 | <0.001 | <0.001 | <0.001 | <0.001 |
| 变量 | 赋值 |
|---|---|
| 区域 | 0=东部,1=中部,2=西部 |
| 机构类型 | 0=社区卫生服务中心,1=乡镇卫生院 |
| 注册全科医师数 | 实测值 |
| 执业(助理)医师数 | 实测值 |
| 医疗收入占总收入比重 | 实测值 |
| 医保基金占医疗收入比重 | 实测值 |
| 心电图机数量分组 | 0=1台,1=2台,2=3台及以上 |
| 末梢血糖仪 | 0=1~3台,1=4~6台,2=7台及以上 |
| 配备抗高血压基本药物品种数分组 | 0=1~3种,1=4~6种,2=7~9种,3=10种及以上 |
| 配备降血糖基本药物品种数分组 | 0=1~3种,1=4~6种,2=7~9种,3=10种及以上 |
| 2型糖尿病患者续约率 | 实测值 |
| 2型糖尿病患者规范管理率 | 实测值 |
| 年诊疗糖尿病人次对数 | 实测值 |
| 高血压患者续约率 | 实测值 |
| 高血压患者规范管理率 | 实测值 |
| 年诊疗高血压病人次对数 | 实测值 |
Table 7 Variable assignment for multiple linear regression analysis of factors influencing the provision of diagnosis, treatment, and health management services for hypertension and diabetes in primary medical and health institutions
| 变量 | 赋值 |
|---|---|
| 区域 | 0=东部,1=中部,2=西部 |
| 机构类型 | 0=社区卫生服务中心,1=乡镇卫生院 |
| 注册全科医师数 | 实测值 |
| 执业(助理)医师数 | 实测值 |
| 医疗收入占总收入比重 | 实测值 |
| 医保基金占医疗收入比重 | 实测值 |
| 心电图机数量分组 | 0=1台,1=2台,2=3台及以上 |
| 末梢血糖仪 | 0=1~3台,1=4~6台,2=7台及以上 |
| 配备抗高血压基本药物品种数分组 | 0=1~3种,1=4~6种,2=7~9种,3=10种及以上 |
| 配备降血糖基本药物品种数分组 | 0=1~3种,1=4~6种,2=7~9种,3=10种及以上 |
| 2型糖尿病患者续约率 | 实测值 |
| 2型糖尿病患者规范管理率 | 实测值 |
| 年诊疗糖尿病人次对数 | 实测值 |
| 高血压患者续约率 | 实测值 |
| 高血压患者规范管理率 | 实测值 |
| 年诊疗高血压病人次对数 | 实测值 |
| 变量 | 高血压诊疗人次 | 高血压患者规范管理率 | 血压控制率 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β | 95%CI | SE | t值 | P值 | β | 95%CI | SE | t值 | P值 | β | 95%CI | SE | t值 | P值 | |
| 区域(以东部为参照) | |||||||||||||||
| 中部 | -0.246 | -0.374~-0.117 | 0.065 | -3.750 | <0.001 | 0.055 | 0.034~0.075 | 0.010 | 5.270 | <0.001 | 0.176 | 0.153~0.200 | 0.012 | 14.770 | <0.001 |
| 西部 | -0.762 | -0.902~-0.621 | 0.072 | -10.640 | <0.001 | 0.087 | 0.065~0.110 | 0.011 | 7.600 | <0.001 | 0.133 | 0.107~0.159 | 0.013 | 10.010 | <0.001 |
| 机构类型(以社区卫生服务中心为参照) | |||||||||||||||
| 乡镇卫生院 | -0.213 | -0.329~-0.097 | 0.059 | -3.600 | <0.001 | 0.057 | 0.039~0.076 | 0.009 | 6.110 | <0.001 | 0.025 | 0.003~0.046 | 0.011 | 2.280 | 0.023 |
| 心电图机数量分组(以1台为参照) | |||||||||||||||
| 2台 | 0.030 | -0.134~0.193 | 0.083 | 0.360 | 0.722 | 0.007 | -0.019~0.033 | 0.013 | 0.510 | 0.611 | 0.044 | 0.014~0.074 | 0.015 | 2.880 | 0.004 |
| 3台及以上 | 0.117 | -0.040~0.274 | 0.080 | 1.460 | 0.144 | 0.007 | -0.018~0.032 | 0.013 | 0.530 | 0.595 | 0.036 | 0.007~0.065 | 0.015 | 2.450 | 0.014 |
| 抗高血压基本药物分组(以1~3种为参照) | |||||||||||||||
| 4~6种 | 0.334 | 0.120~0.549 | 0.109 | 3.050 | 0.002 | -0.012 | -0.046~0.022 | 0.017 | -0.680 | 0.500 | -0.012 | -0.052~0.027 | 0.020 | -0.610 | 0.539 |
| 7~9种 | 0.579 | 0.366~0.792 | 0.109 | 5.330 | <0.001 | 0.001 | -0.033~0.035 | 0.017 | 0.070 | 0.947 | -0.001 | -0.040~0.038 | 0.020 | -0.040 | 0.966 |
| 10种及以上 | 0.892 | 0.641~1.144 | 0.128 | 6.960 | <0.001 | 0.007 | -0.033~0.047 | 0.021 | 0.340 | 0.731 | 0.018 | -0.029~0.064 | 0.024 | 0.750 | 0.454 |
| 执业(助理)医师数 | -0.059 | -0.181~0.064 | 0.063 | -0.940 | 0.346 | -0.032 | -0.052~-0.013 | 0.010 | -3.240 | 0.001 | -0.028 | -0.051~-0.006 | 0.011 | -2.480 | 0.013 |
| 注册全科医师数 | 0.512 | 0.425~0.599 | 0.044 | 11.510 | <0.001 | 0.001 | -0.013~0.015 | 0.007 | 0.180 | 0.861 | 0.000 | -0.017~0.016 | 0.008 | -0.020 | 0.980 |
| 医疗收入占总收入比重 | 0.805 | 0.416~1.195 | 0.199 | 4.050 | <0.001 | -0.044 | -0.106~0.018 | 0.032 | -1.400 | 0.163 | -0.060 | -0.131~0.012 | 0.036 | -1.640 | 0.101 |
| 医保收入占医疗收入比重 | 0.974 | 0.666~1.283 | 0.157 | 6.190 | <0.001 | 0.056 | 0.007~0.106 | 0.025 | 2.240 | 0.025 | 0.062 | 0.005~0.118 | 0.029 | 2.140 | 0.033 |
| 高血压患者续约率 | 0.121 | 0.037~0.205 | 0.043 | 2.830 | 0.005 | 0.019 | 0.006~0.033 | 0.007 | 2.850 | 0.004 | 0.012 | -0.003~0.028 | 0.008 | 1.590 | 0.113 |
| 高血压患者规范管理率 | -0.159 | -0.397~0.079 | 0.121 | -1.310 | 0.190 | — | — | — | — | — | — | — | — | — | — |
| 年诊疗高血压病人次 | — | — | — | — | — | -0.004 | -0.01~0.002 | 0.003 | -1.310 | 0.190 | 0.004 | -0.003~0.011 | 0.004 | 1.180 | 0.238 |
| 常数 | 6.292 | 5.120~7.464 | 0.598 | 10.530 | <0.001 | 4.348 | 4.253~4.443 | 0.048 | 89.780 | <0.001 | 4.150 | 4.041~4.260 | 0.056 | 74.420 | <0.001 |
Table 8 Multiple linear regression analysis of factors influencing the provision of diagnosis, treatment, and health management services for hypertension in primary medical and health institutions
| 变量 | 高血压诊疗人次 | 高血压患者规范管理率 | 血压控制率 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β | 95%CI | SE | t值 | P值 | β | 95%CI | SE | t值 | P值 | β | 95%CI | SE | t值 | P值 | |
| 区域(以东部为参照) | |||||||||||||||
| 中部 | -0.246 | -0.374~-0.117 | 0.065 | -3.750 | <0.001 | 0.055 | 0.034~0.075 | 0.010 | 5.270 | <0.001 | 0.176 | 0.153~0.200 | 0.012 | 14.770 | <0.001 |
| 西部 | -0.762 | -0.902~-0.621 | 0.072 | -10.640 | <0.001 | 0.087 | 0.065~0.110 | 0.011 | 7.600 | <0.001 | 0.133 | 0.107~0.159 | 0.013 | 10.010 | <0.001 |
| 机构类型(以社区卫生服务中心为参照) | |||||||||||||||
| 乡镇卫生院 | -0.213 | -0.329~-0.097 | 0.059 | -3.600 | <0.001 | 0.057 | 0.039~0.076 | 0.009 | 6.110 | <0.001 | 0.025 | 0.003~0.046 | 0.011 | 2.280 | 0.023 |
| 心电图机数量分组(以1台为参照) | |||||||||||||||
| 2台 | 0.030 | -0.134~0.193 | 0.083 | 0.360 | 0.722 | 0.007 | -0.019~0.033 | 0.013 | 0.510 | 0.611 | 0.044 | 0.014~0.074 | 0.015 | 2.880 | 0.004 |
| 3台及以上 | 0.117 | -0.040~0.274 | 0.080 | 1.460 | 0.144 | 0.007 | -0.018~0.032 | 0.013 | 0.530 | 0.595 | 0.036 | 0.007~0.065 | 0.015 | 2.450 | 0.014 |
| 抗高血压基本药物分组(以1~3种为参照) | |||||||||||||||
| 4~6种 | 0.334 | 0.120~0.549 | 0.109 | 3.050 | 0.002 | -0.012 | -0.046~0.022 | 0.017 | -0.680 | 0.500 | -0.012 | -0.052~0.027 | 0.020 | -0.610 | 0.539 |
| 7~9种 | 0.579 | 0.366~0.792 | 0.109 | 5.330 | <0.001 | 0.001 | -0.033~0.035 | 0.017 | 0.070 | 0.947 | -0.001 | -0.040~0.038 | 0.020 | -0.040 | 0.966 |
| 10种及以上 | 0.892 | 0.641~1.144 | 0.128 | 6.960 | <0.001 | 0.007 | -0.033~0.047 | 0.021 | 0.340 | 0.731 | 0.018 | -0.029~0.064 | 0.024 | 0.750 | 0.454 |
| 执业(助理)医师数 | -0.059 | -0.181~0.064 | 0.063 | -0.940 | 0.346 | -0.032 | -0.052~-0.013 | 0.010 | -3.240 | 0.001 | -0.028 | -0.051~-0.006 | 0.011 | -2.480 | 0.013 |
| 注册全科医师数 | 0.512 | 0.425~0.599 | 0.044 | 11.510 | <0.001 | 0.001 | -0.013~0.015 | 0.007 | 0.180 | 0.861 | 0.000 | -0.017~0.016 | 0.008 | -0.020 | 0.980 |
| 医疗收入占总收入比重 | 0.805 | 0.416~1.195 | 0.199 | 4.050 | <0.001 | -0.044 | -0.106~0.018 | 0.032 | -1.400 | 0.163 | -0.060 | -0.131~0.012 | 0.036 | -1.640 | 0.101 |
| 医保收入占医疗收入比重 | 0.974 | 0.666~1.283 | 0.157 | 6.190 | <0.001 | 0.056 | 0.007~0.106 | 0.025 | 2.240 | 0.025 | 0.062 | 0.005~0.118 | 0.029 | 2.140 | 0.033 |
| 高血压患者续约率 | 0.121 | 0.037~0.205 | 0.043 | 2.830 | 0.005 | 0.019 | 0.006~0.033 | 0.007 | 2.850 | 0.004 | 0.012 | -0.003~0.028 | 0.008 | 1.590 | 0.113 |
| 高血压患者规范管理率 | -0.159 | -0.397~0.079 | 0.121 | -1.310 | 0.190 | — | — | — | — | — | — | — | — | — | — |
| 年诊疗高血压病人次 | — | — | — | — | — | -0.004 | -0.01~0.002 | 0.003 | -1.310 | 0.190 | 0.004 | -0.003~0.011 | 0.004 | 1.180 | 0.238 |
| 常数 | 6.292 | 5.120~7.464 | 0.598 | 10.530 | <0.001 | 4.348 | 4.253~4.443 | 0.048 | 89.780 | <0.001 | 4.150 | 4.041~4.260 | 0.056 | 74.420 | <0.001 |
| 变量 | 糖尿病诊疗人次 | 糖尿病规范管理率 | 血糖控制率 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β | 95%CI | SE | t值 | P值 | β | 95%CI | SE | t值 | P值 | β | 95%CI | SE | t值 | P值 | |
| 区域(以东部为参照) | |||||||||||||||
| 中部 | -0.132 | -0.267~0.004 | 0.069 | -1.900 | 0.057 | 0.061 | 0.040~0.083 | 0.011 | 5.740 | <0.001 | 0.232 | 0.205~0.260 | 0.014 | 16.720 | <0.001 |
| 西部 | -0.683 | -0.840~-0.526 | 0.080 | -8.530 | <0.001 | 0.083 | 0.059~0.108 | 0.013 | 6.650 | <0.001 | 0.151 | 0.119~0.183 | 0.016 | 9.290 | <0.001 |
| 机构类型(以社区卫生服务中心为参照) | |||||||||||||||
| 乡镇卫生院 | -0.219 | -0.341~-0.097 | 0.062 | -3.510 | <0.001 | 0.069 | 0.050~0.088 | 0.010 | 7.180 | <0.001 | 0.035 | 0.011~0.060 | 0.013 | 2.820 | 0.005 |
| 末梢血糖仪数量分组(以1~3台为参照) | |||||||||||||||
| 4~6台 | -0.121 | -0.425~0.183 | 0.155 | -0.780 | 0.435 | -0.009 | -0.057~0.038 | 0.024 | -0.390 | 0.695 | -0.008 | -0.069~0.054 | 0.031 | -0.240 | 0.809 |
| 7台及以上 | -0.091 | -0.402~0.221 | 0.159 | -0.570 | 0.567 | -0.004 | -0.052~0.044 | 0.025 | -0.160 | 0.872 | -0.023 | -0.086~0.040 | 0.032 | -0.720 | 0.474 |
| 降血糖基本药物品种数分组(以1~3种为参照) | |||||||||||||||
| 4~6种 | 0.628 | 0.418~0.839 | 0.107 | 5.860 | <0.001 | 0.012 | -0.021~0.044 | 0.017 | 0.690 | 0.493 | -0.044 | -0.087~-0.002 | 0.022 | -2.030 | 0.042 |
| 7~9种 | 1.060 | 0.847~1.273 | 0.109 | 9.760 | <0.001 | 0.013 | -0.021~0.047 | 0.017 | 0.760 | 0.447 | -0.027 | -0.070~0.017 | 0.022 | -1.190 | 0.233 |
| 10种及以上 | 1.475 | 1.245~1.704 | 0.117 | 12.620 | <0.001 | 0.025 | -0.012~0.061 | 0.019 | 1.310 | 0.189 | 0.002 | -0.045~0.050 | 0.024 | 0.100 | 0.919 |
| 执业(助理)医师数 | 0.139 | 0.009~0.269 | 0.066 | 2.090 | 0.037 | -0.037 | -0.057~-0.017 | 0.010 | -3.570 | <0.001 | -0.035 | -0.061~-0.008 | 0.013 | -2.590 | 0.010 |
| 注册全科医师数 | 0.451 | 0.360~0.543 | 0.047 | 9.670 | <0.001 | -0.009 | -0.023~0.006 | 0.007 | -1.210 | 0.228 | -0.009 | -0.027~0.010 | 0.010 | -0.900 | 0.367 |
| 医疗收入占总收入比重 | 0.955 | 0.544~1.367 | 0.210 | 4.550 | <0.001 | -0.021 | -0.086~0.043 | 0.033 | -0.650 | 0.516 | -0.062 | -0.145~0.021 | 0.042 | -1.470 | 0.143 |
| 医保收入占医疗收入比重 | 0.759 | 0.434~1.084 | 0.166 | 4.580 | <0.001 | 0.062 | 0.011~0.113 | 0.026 | 2.400 | 0.016 | 0.106 | 0.040~0.172 | 0.033 | 3.160 | 0.002 |
| 糖尿病患者续约率 | 0.107 | 0.021~0.194 | 0.044 | 2.440 | 0.015 | 0.021 | 0.008~0.034 | 0.007 | 3.070 | 0.002 | 0.016 | -0.001~0.034 | 0.009 | 1.820 | 0.069 |
| 糖尿病患者规范管理率 | -0.081 | -0.314~0.153 | 0.119 | -0.680 | 0.498 | — | — | — | — | — | — | — | — | — | — |
| 年诊疗糖尿病人次 | — | — | — | — | — | -0.002 | -0.008~0.004 | 0.003 | -0.680 | 0.498 | 0.007 | 0000~0.014 | 0.004 | 1.870 | 0.062 |
| 常数 | 4.340 | 3.161~5.518 | 0.601 | 7.220 | <0.001 | 4.328 | 4.231~4.426 | 0.050 | 87.100 | <0.001 | 4.104 | 3.977~4.230 | 0.065 | 63.560 | <0.001 |
Table 9 Multiple linear regression analysis of factors influencing the provision of diagnosis, treatment, and health management services for diabetes in primary medical and health institutions
| 变量 | 糖尿病诊疗人次 | 糖尿病规范管理率 | 血糖控制率 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β | 95%CI | SE | t值 | P值 | β | 95%CI | SE | t值 | P值 | β | 95%CI | SE | t值 | P值 | |
| 区域(以东部为参照) | |||||||||||||||
| 中部 | -0.132 | -0.267~0.004 | 0.069 | -1.900 | 0.057 | 0.061 | 0.040~0.083 | 0.011 | 5.740 | <0.001 | 0.232 | 0.205~0.260 | 0.014 | 16.720 | <0.001 |
| 西部 | -0.683 | -0.840~-0.526 | 0.080 | -8.530 | <0.001 | 0.083 | 0.059~0.108 | 0.013 | 6.650 | <0.001 | 0.151 | 0.119~0.183 | 0.016 | 9.290 | <0.001 |
| 机构类型(以社区卫生服务中心为参照) | |||||||||||||||
| 乡镇卫生院 | -0.219 | -0.341~-0.097 | 0.062 | -3.510 | <0.001 | 0.069 | 0.050~0.088 | 0.010 | 7.180 | <0.001 | 0.035 | 0.011~0.060 | 0.013 | 2.820 | 0.005 |
| 末梢血糖仪数量分组(以1~3台为参照) | |||||||||||||||
| 4~6台 | -0.121 | -0.425~0.183 | 0.155 | -0.780 | 0.435 | -0.009 | -0.057~0.038 | 0.024 | -0.390 | 0.695 | -0.008 | -0.069~0.054 | 0.031 | -0.240 | 0.809 |
| 7台及以上 | -0.091 | -0.402~0.221 | 0.159 | -0.570 | 0.567 | -0.004 | -0.052~0.044 | 0.025 | -0.160 | 0.872 | -0.023 | -0.086~0.040 | 0.032 | -0.720 | 0.474 |
| 降血糖基本药物品种数分组(以1~3种为参照) | |||||||||||||||
| 4~6种 | 0.628 | 0.418~0.839 | 0.107 | 5.860 | <0.001 | 0.012 | -0.021~0.044 | 0.017 | 0.690 | 0.493 | -0.044 | -0.087~-0.002 | 0.022 | -2.030 | 0.042 |
| 7~9种 | 1.060 | 0.847~1.273 | 0.109 | 9.760 | <0.001 | 0.013 | -0.021~0.047 | 0.017 | 0.760 | 0.447 | -0.027 | -0.070~0.017 | 0.022 | -1.190 | 0.233 |
| 10种及以上 | 1.475 | 1.245~1.704 | 0.117 | 12.620 | <0.001 | 0.025 | -0.012~0.061 | 0.019 | 1.310 | 0.189 | 0.002 | -0.045~0.050 | 0.024 | 0.100 | 0.919 |
| 执业(助理)医师数 | 0.139 | 0.009~0.269 | 0.066 | 2.090 | 0.037 | -0.037 | -0.057~-0.017 | 0.010 | -3.570 | <0.001 | -0.035 | -0.061~-0.008 | 0.013 | -2.590 | 0.010 |
| 注册全科医师数 | 0.451 | 0.360~0.543 | 0.047 | 9.670 | <0.001 | -0.009 | -0.023~0.006 | 0.007 | -1.210 | 0.228 | -0.009 | -0.027~0.010 | 0.010 | -0.900 | 0.367 |
| 医疗收入占总收入比重 | 0.955 | 0.544~1.367 | 0.210 | 4.550 | <0.001 | -0.021 | -0.086~0.043 | 0.033 | -0.650 | 0.516 | -0.062 | -0.145~0.021 | 0.042 | -1.470 | 0.143 |
| 医保收入占医疗收入比重 | 0.759 | 0.434~1.084 | 0.166 | 4.580 | <0.001 | 0.062 | 0.011~0.113 | 0.026 | 2.400 | 0.016 | 0.106 | 0.040~0.172 | 0.033 | 3.160 | 0.002 |
| 糖尿病患者续约率 | 0.107 | 0.021~0.194 | 0.044 | 2.440 | 0.015 | 0.021 | 0.008~0.034 | 0.007 | 3.070 | 0.002 | 0.016 | -0.001~0.034 | 0.009 | 1.820 | 0.069 |
| 糖尿病患者规范管理率 | -0.081 | -0.314~0.153 | 0.119 | -0.680 | 0.498 | — | — | — | — | — | — | — | — | — | — |
| 年诊疗糖尿病人次 | — | — | — | — | — | -0.002 | -0.008~0.004 | 0.003 | -0.680 | 0.498 | 0.007 | 0000~0.014 | 0.004 | 1.870 | 0.062 |
| 常数 | 4.340 | 3.161~5.518 | 0.601 | 7.220 | <0.001 | 4.328 | 4.231~4.426 | 0.050 | 87.100 | <0.001 | 4.104 | 3.977~4.230 | 0.065 | 63.560 | <0.001 |
| [1] |
国家卫生健康委统计信息中心.第六次全国卫生服务调查分析[M].北京:人民卫生出版社,2021.
|
| [2] |
陈锦清, 方静, 庄伟, 等. 基层全科医生胜任力对老年高血压患者自我管理能力的影响[J]. 中华高血压杂志, 2022, 30(12): 1205-1210. DOI: 10.16439/j.issn.1673-7245.2022.12.020.
|
| [3] |
廖雨娟, 林娟, 林丽娜. 基层医务人员糖尿病自我管理教育能力的调查[J]. 中国继续医学教育, 2020, 12(30): 83-87. DOI: 10.3969/j.issn.1674-9308.2020.30.024.
|
| [4] |
王娜萌, 廖康, 李丽琪, 等. 基层医生自评高血压健康评估水平及影响因素研究[J]. 中国全科医学, 2023, 26(7): 853-861. DOI: 10.12114/j.issn.1007-9572.2022.0777.
|
| [5] |
冯江星, 林燕铭, 李龙, 等. 影响高血压和2型糖尿病患者健康管理的基层卫生人力因素研究[J]. 实用预防医学, 2021, 28(2): 246-249. DOI: 10.3969/j.issn.1006-3110.2021.02.032.
|
| [6] |
刘俊平, 邓香. 基层医务人员对高血压及用药的认知调查[J]. 中国乡村医药, 2022, 29(18): 32-33.
|
| [7] |
张小娟, 姜骁桐, 郑见立, 等. 基层医疗机构高血压与糖尿病治疗基本药物配备与可获得情况分析[J]. 中国卫生政策研究, 2020, 13(7): 58-65. DOI: 10.3969/j.issn.1674-2982.2020.07.010.
|
| [8] |
喜杨, 陈源源, 郝玉明, 等. 不同基层医疗机构中高血压基本药物的可及性调查[J]. 中华高血压杂志, 2021, 29(9): 825-833.
|
| [9] |
沈晨, 李辛然, 陶群山. 基层家庭医生服务质量与高血压患者满意度的研究[J]. 齐齐哈尔医学院学报, 2022, 43(3): 253-257.
|
| [10] |
国家卫生健康委员会. 中国卫生健康统计年鉴-2024[M]. 北京: 中国协和医科大学出版社, 2025.
|
| [11] |
国家统计局社会科技,文化产业统计司. 中国统计年鉴-2024[M]. 北京: 中国统计出版社, 2024.
|
| [12] |
周好奇, 王馨, 杨瑛, 等. 我国社区门诊就诊高血压患者的用药现状[J]. 中华高血压杂志, 2022, 30(7): 670-675.
|
| [13] |
张硕, 付英杰, 常乐乐, 等. 基于ICCC框架的山东省农村高血压健康管理现状的质性研究[J]. 中国全科医学, 2023, 26(16): 1972-1978, 1983. DOI: 10.12114/j.issn.1007-9572.2022.0677.
|
| [14] |
陈发青, 常利军, 何虎鹏, 等. 甘肃省高血压、糖尿病患者管理情况及相关因素分析[J]. 中国初级卫生保健, 2023, 37(2): 40-43.
|
| [1] | ZHOU Xiaoya, WANG Weikai, LIU Qian, LI Jianhua, SUN Bo, WANG Yanxia. Study of the Interaction between Sleep Quality and Melatonin Receptor 1B Gene Polymorphism on Gestational Hypertension [J]. Chinese General Practice, 2026, 29(21): 2975-2981. |
| [2] | WANG Yang, ZHAO Shiting, CHEN Yingying, SUN Zilin, QIU Shanhu. Key Points of Exercise Intervention and Implementation for People with Complications of Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(21): 2989-2994. |
| [3] | LI Jiawei, GAO Xinyi, GE Aoqi, LI Juanjuan, YUAN Beibei. Demand and Associated Factors for Integrated Medical Care and Preventive Services among Patients with Type 2 Diabetes [J]. Chinese General Practice, 2026, 29(21): 3028-3039. |
| [4] | PAN Ziyun, YIN Hao, LIN Zhirou, MAO Jingyi, HUANG Yan, LUO Yanhua, XIAO Jiafu, HU Yin. From Mechanism to Therapy: Diabetic Autonomic Neuropathy [J]. Chinese General Practice, 2026, 29(21): 2982-2988. |
| [5] | AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua. Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology [J]. Chinese General Practice, 2026, 29(21): 2995-3003. |
| [6] | JIAN Yingchun, ZENG Yongqin, ZHANG Haiping, WANG Zhengdi, AN Ke, YAN Rui. Recent Advances in Mitochondrial Dysfunction in Chronic Metabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2577-2584. |
| [7] | MIAO Jingjie, ZHANG Jinwen, WU Qianhao, HAN Peipei. Research Advances on the Effects of Intermittent Fasting on Cardiometabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2538-2545. |
| [8] | LI Yachan, YANG Yang, XU Qianting, KE Tingyu. Association between the Chinese Visceral Adiposity Index and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(18): 2482-2488. |
| [9] | LI Menglin, DING Fang, QIAN Yu, PU Dong, DU Qianqian, GUAN Tianhang, HE Yilin. Study on Glycemic Control Status and Influencing Factors among Community Diabetic Patients [J]. Chinese General Practice, 2026, 29(17): 2334-2339. |
| [10] | WANG Rui, LUO Dan, YANG Cuicui, WENG Xinyi, WANG Yubing, XU Jingjing. Complex Network Analysis of Resilience in Adolescents with Type 1 Diabetes Mellitus Based on Multi-sourced Stigma [J]. Chinese General Practice, 2026, 29(16): 2264-2272. |
| [11] | FU Mingyuan, YU Xiaoyi, GE Caiying, KONG Min. Impaired Awareness of Hypoglycemia: Prevalence and Determinants among Community-based Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(16): 2252-2258. |
| [12] | XU Ping, MA Yan, HUANG Li, HE Meiliang, HOU Yunfeng, WANG Dewang, SUN Panpan, LIU Zheng, GUO Yanfang, XU Ying. Association between Weight-adjusted Waist Index and Comorbidity of Hypertension, Diabetes and Dyslipidemia in Community-dwelling Adults [J]. Chinese General Practice, 2026, 29(16): 2198-2204. |
| [13] | QIU Xinyu, ZHAO Qian, CHEN Yufei, JIAMULE· Maimaitiyiming, HAN Congcong, AIKEDAN· Aierken, LI Xiaomei, YANG Yining. Weight Status and Metabolic Characteristics on the Longitudinal Trajectory of Systolic Blood Pressure: a Cohort Study [J]. Chinese General Practice, 2026, 29(15): 2006-2013. |
| [14] | LIU Fan, CHEN Qiuyu, LI Jing. Development and Validation of a Nighttime Hypertension Screening Model for Subclinical High-risk Populations: a Single-center Cohort Study [J]. Chinese General Practice, 2026, 29(15): 1998-2005. |
| [15] | JIN Chunhua, ZHANG Yawen, LI Lianxi. Association between Serum Bilirubin Within the Normal Range and Carotid Plaques in Elderly Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(15): 1986-1991. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||